How should impetigo on the chin be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo on the Chin

Start with topical mupirocin 2% ointment applied three times daily for 5-7 days as first-line treatment for localized impetigo on the chin. 1, 2

First-Line Topical Therapy

  • Mupirocin 2% ointment is the gold standard treatment, with clinical efficacy rates of 71-93% in controlled trials and FDA approval specifically for impetigo caused by S. aureus and S. pyogenes. 1, 2
  • Apply three times daily for 5-7 days to the affected area on the chin. 1, 3
  • Retapamulin 1% ointment twice daily for 5 days is an effective alternative if mupirocin is unavailable. 1, 3
  • Avoid bacitracin and neomycin—they are considerably less effective and should not be used. 1, 4

When to Escalate to Oral Antibiotics

Switch to systemic therapy if any of the following occur:

  • No improvement after 48-72 hours (or 3-5 days) of topical therapy 1, 4
  • Extensive disease involving multiple sites 4, 3
  • Systemic symptoms present (fever, malaise, lymphadenopathy) 1, 4
  • Need to limit spread to others, such as during outbreaks 4
  • Lesions on face/mouth where topical therapy is impractical 4

Oral Antibiotic Selection

For Presumed MSSA (Methicillin-Susceptible S. aureus):

  • Dicloxacillin 250 mg four times daily for adults (7-10 days) 1, 4
  • Cephalexin 250-500 mg four times daily for adults (7-10 days) as an alternative 1, 4

For Suspected or Confirmed MRSA:

  • Clindamycin 300-450 mg three times daily for adults 1, 4
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily 1, 4
  • Doxycycline (contraindicated in children under 8 years) 1, 3

Critical Pitfalls to Avoid

  • Never use penicillin alone—it lacks adequate coverage against S. aureus 1, 4
  • Do not use rifampin as monotherapy or adjunctive therapy for skin infections 1
  • Avoid tetracyclines (doxycycline, minocycline) in children under 8 years 1, 3
  • Do not use topical clindamycin cream (designed for acne, not impetigo) 4
  • Avoid cephalosporins if patient has type 1 hypersensitivity (anaphylaxis/hives) to β-lactams 4

Infection Control and Prevention

  • Keep lesions covered with clean, dry bandages 4
  • Maintain good personal hygiene with regular handwashing 4
  • Avoid sharing personal items that contact the skin (towels, equipment) 5, 4
  • For athletes, exclude from participation until 24 hours after initiation of effective antimicrobial therapy 4

When to Obtain Cultures

Cultures are not routinely necessary for typical limited impetigo, but obtain them if: 4, 3

  • Treatment failure occurs
  • MRSA is suspected
  • Recurrent infections develop
  • Patient is immunocompromised

Special Populations

  • Pediatric patients: Use mupirocin 2% topical ointment as first-line; avoid tetracyclines under age 8 1, 4
  • Pregnant patients: Cephalexin is a safe alternative 4
  • Penicillin-allergic patients: Clindamycin is the preferred alternative 4
  • Immunocompromised patients: Lower threshold for oral antibiotics; monitor closely for treatment failure or deeper infection 4

Treatment During Outbreaks

  • Use systemic antimicrobials to help eliminate nephritogenic strains of S. pyogenes from the community 5, 4
  • Consider decolonization strategies using topical nasal mupirocin therapy for S. aureus carriers 4
  • Involve public health authorities for outbreak management 5

References

Guideline

Treatment of Scalp Skin Biopsy Site Infection Resembling Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Impetigo on Hand Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.